Open AccessP471: ERYTHROID/MEGAKARYOCYTIC DIFFERENTIATION BIAS IN BONE MARROW OF AML/MDS PATIENTS AFTER DECITABINE TREATMENT
Author(s) -
Tiso F.,
Graaf A. O.,
Kroeze L. I.,
Reijden B. A.,
Langemeijer S. M. C.,
Hebeda K. M.,
Jansen J. H.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844772.42117.cb
Subject(s) - decitabine , cancer research , azacitidine , bone marrow , myeloid leukemia , myeloid , myelodysplastic syndromes , hypomethylating agent , cytarabine , medicine , biology , dna methylation , gene , genetics , gene expression